Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2679)	1/26/2010 12:44:52 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

THLD was up 18.22% at its intraday H and is still up 10.4% but it seems to be drifting down.<g> Volume of > 216Ks is below 3x its ADV of around 81.6Ks bigcharts.marketwatch.com THLD announced yesterday after the market closed, data from a PI/II of TH-302 in patients with GI Cas. Of the 38 patients assessed, 12 (32%) had a RECIST criteria partial response. The stock rallied 27.6% in AHs. THLD had been trimming its losses in the last 4Qs and trying to form a base at the $1.75 to $1.80 level since Nov. It had a previous small spike on Jan11 The stock is starting to come off its near term DT coming from its Oct12 H at $3.87 bigcharts.marketwatch.com THLD has no significant LTD but has been burning its cash at a good clip. The insiders reportedly hold >50% In Oct it raised about $25M in a private placement of stocks and warrants. The ACTAY is $3, but with some good news it seems the stock could get to the $8 level.<g> bigcharts.marketwatch.com Bernard